Coya Therapeutics, Inc.
COYA • NASDAQ
Coya Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arun Swaminathan, with a market cap of $92.9M.
Market Cap$92.9M
Employees6.0
CEOArun Swaminathan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Coya Therapeutics, Inc. FAQ
Common questions about Coya Therapeutics, Inc.
Coya Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $71.7K.
Coya Therapeutics, Inc. has approximately 6 employees.